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Influence of common variants near INSIG2, in FTO, and near MC4R
genes on overweight and the metabolic profile in adolescence: the
TRAILS (TRacking Adolescents’ Individual Lives Survey) Study1–3
Eryn T Liem, Judith M Vonk, Pieter JJ Sauer, Gerrit van der Steege, Elvira Oosterom, Ronald P Stolk, and Harold Snieder
ABSTRACT
Background: Overweight is a complex trait in which both environ-
mental and genetic factors play a role.
Objective: We aimed to evaluate the influence of common genetic
variants identified by genome-wide association studies on over-
weight and the metabolic profile in adolescence.
Design: In a population-based cohort of 663 girls and 612 boys
aged 16 y, weight, height, skinfold thicknesses, percentage body
fat, waist circumference, blood pressure, glucose, insulin, lipid pro-
file, and DNA were obtained. We defined overweight according to
international criteria. We performed multiple linear and logistic re-
gression analyses to assess the influence of candidate single nucle-
otide polymorphisms near the INSIG2, in the FTO, and near the
MC4R genes and repeated-measures analyses of available body
mass index (BMI) and skinfold thickness data across 3 visits at ages
11, 13.5, and 16 y.
Results: A total of 15.1% of participants were overweight or obese
at age 16 y. No associations with INSIG2 were found. Common
variation in the FTO gene was associated with sex-specific z scores
of BMI (B: 0.11; 95% CI: 0.03, 0.19), sum of skinfold thicknesses
(B: 0.12; 95% CI: 0.04, 0.20), percentage body fat (B: 0.11; 95%
CI: 0.03, 0.19), waist circumference (B: 0.11; 95% CI: 0.03, 0.19),
fasting glucose (B: 0.10; 95% CI: 0.00, 0.20), and overweight (odds
ratio: 1.34; 95% CI: 1.06, 1.69) at age 16 y. Repeated-measures
analyses confirmed the associations for BMI and sum of skinfold
thicknesses, and physical activity did not modify these associations.
Common variation near the MC4R gene was associated with BMI in
cross-sectional (B: 0.11; 95% CI: 0.02, 0.20) and repeated-measures
(B: 0.12; 95% CI: 0.03, 0.20) analyses.
Conclusions: Common variation in the FTO gene is associated with
overall and abdominal adiposity. Variation near the MC4R gene is
associated with BMI. These findings in adolescents strengthen and
extend the results from previous research. Am J Clin Nutr
2010;91:321–8.
INTRODUCTION
Overweight is associated with an increased risk of diabetes,
hypertension, dyslipidemia, and cardiovascular disease. It is
known that childhood overweight tends to track into adolescence
and adulthood (1, 2). Moreover, epidemiologic studies have
shown that, already in childhood, total and abdominal fat appear
to be significantly associated with an unfavorable metabolic
profile, including insulin resistance, elevated LDL cholesterol,
and decreased HDL cholesterol (3, 4). Thus, childhood over-
weight poses a major public health concern.
Lifestyle factors such as increased energy intake and decreased
physical activity are probably the main determinants of the in-
creased prevalence of childhood overweight. Genetic background
predicts an individual’s susceptibility to weight change resulting
from a certain lifestyle (5, 6). Multiple genes are involved,
probably interacting with each other and with environmental
factors, implying a multifactorial trait. Recently, genome-wide
association studies in large cohorts have identified common
variants associated with overweight. The variant near INSIG2
was the first to be associated with BMI in a genome-wide as-
sociation study (7). Although it was shown that variation near
INSIG2 predicted the amount of weight loss during treatment of
obese children and adolescents (8), the association between the
variant near INSIG2 and overweight was not confirmed by other
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studies (9–13). An association between common variation in the
FTO gene and BMI was identified by 3 groups (14–16), 2 of
which used genome-wide association studies (15, 16). This was
confirmed in multiple follow-up studies (17–25). Recently,
common variants near the MC4R gene have been found to in-
fluence BMI in whites (26) and waist circumference and insulin
resistance in Indian Asians (27).
In most of these studies, an association with childhood
overweight was also found, not only for FTO (14, 15, 19, 24, 25)
but also for variants near the INSIG2 (7) and MC4R (26) genes.
In 2 pediatric studies (15, 24), overweight was assessed on the
basis of BMI and a dual-energy X-ray absorptiometry scan,
more specifically measuring overall adipose tissue. However,
few studies have evaluated abdominal fat (28) or overweight-
related metabolic profiles (29) in children. These are important
because they confer an increased risk of later metabolic com-
plications such as diabetes and cardiovascular disease. Because
results obtained by Wa˚hle´n et al (30) suggest that FTO could be
involved in body weight regulation through lipolysis, it would
also be interesting, from a pathophysiologic point of view, to
evaluate whether these genetic variants are associated with
metabolic traits, such as lipids, and, if so, whether these asso-
ciations are driven by BMI, as was found in studies of adults
(31).
The aim of this study was to assess the influence of common
genetic variants found through genome-wide association studies,
more specifically variants near the INSIG2, in the FTO, and near
the MC4R genes, on overweight and its related metabolic traits
at age 16 y. We assessed overweight by BMI, total body fat by
sum of skinfold thicknesses and total body impedance analysis,
abdominal adiposity by waist circumference, and metabolic
profile by blood pressure, glucose, and lipids. In addition, BMI
(at ages 11 and 13.5 y) and sum of skinfold thicknesses (at age
11 y) were available from earlier visits. Finally, we aimed to




Our study was performed in the TRAILS (TRacking Ado-
lescents’ Individual Lives Survey) population, an ongoing Dutch
prospective cohort study assessing both psychosocial and
physical health from preadolescence into adulthood. Sample
selection was described elsewhere (32). In brief, children were
recruited through community registers and through their schools
to obtain a representative sample. The present study included
mainly data from the third assessment visit, during which most
overweight-related data were collected. This visit took place in
2005–2007 at a mean (6SD) age of 16.2 6 0.67 y. In addition,
during 2 previous visits (in 2001–2002 at age 11.1 6 0.55 y and
in 2003–2004 at age 13.5 6 0.52 y), weight and height (first and
second visits) and skinfold thicknesses (first visit only) were
measured, which we included in our repeated-measures analy-
ses. For this study we included participants for whom DNAwas
available (n = 1460). We excluded all participants who were not
of northern European ancestry (n = 161) and the second of all
siblings within the cohort (n = 25), which resulted in a pop-
ulation of 1275 adolescents (52.0% girls). All procedures were
approved by the Dutch Central Committee on Research In-
volving Human Subjects. Written informed consent, including
specific consent to undertake genetic analyses, was obtained
from participants and their parents or custodians.
Measures
We measured weight and height using regularly calibrated
equipment (models 770 and 214, respectively; Seca, Hamburg,
Germany). Body mass index (BMI; in kg/m2) was also calcu-
lated. We defined overweight and obesity according to in-
ternational age- and sex-adjusted BMI criteria (equivalent to the
Dutch 94th and 99.7th percentiles in 1980 for overweight and
obesity, respectively) (33). We obtained triceps, biceps, sub-
scapular, and suprailiac skinfold thicknesses with a Harpenden
skinfold caliper (CMS Instruments, London, United Kingdom);
and the sum of 4 thicknesses was calculated. We measured waist
circumference at the midpoint between the lower costal margin
and the iliac crest. We performed all measurements in duplicate,
and, if the difference between these measurements exceeded
a predefined value, a third measurement was performed. All
available measurements were used to calculate means. We per-
formed a hand-to-foot bioelectrical impedance analysis (type
BIA 101; Akern, Pontassieve, Italy), from which percentage
body fat (%BF) was calculated by using the Deurenberg equa-
tion (34). Systolic (SBP) and diastolic (DBP) blood pressure
were measured in duplicate with a Dinamap Critikon 1846SX
(Critikon Inc, Tampa, FL), from which we calculated means.
We obtained a blood sample after 8 h of fasting for the
measurement of glucose (Roche Diagnostics, Basel, Switzer-
land), insulin (Diagnostic Systems Laboratories Inc, Webster,
TX), triglycerides, total cholesterol, and HDL cholesterol (Ro-
che Diagnostics). LDL cholesterol was calculated according to
Friedewald’s equation (35). The presence of the metabolic
syndrome was determined according to the International Di-
abetes Federation (IDF) criteria (36, 37), based on age-specific
cutoffs for waist circumference, triglycerides, HDL cholesterol,
blood pressure, and glucose.
Questionnaires were filled out to assess pubertal stage
(Physical Development Scale questionnaire; 38) and physical
activity. We asked how many days per week the adolescents
participated in 60 min of moderate or vigorous physical ac-
tivity, from which “sufficient physical activity” was determined
as 5 d/wk, in accordance with international recommendations
(39).
Genotyping
We extracted DNA from buffy coats (n = 1216) or buccal
swabs (Cytobrush) (n = 59) using a manual salting out procedure
similar to the protocol described by Miller et al (40). Geno-
typing was performed on the Illumina BeadStation 500 platform
(Illumina Inc, San Diego, CA) by laboratory personnel blinded
to the true identity of the individual samples. Scan data were
analyzed and genotyped in BeadStudio 3.0 (Illumina Inc, San
Diego, CA). For this study, we used genotype data from
rs7566605 (INSIG2), rs9939609 (FTO), rs17782313 (MC4R),
and rs17700633 (MC4R). Call rates were 100% for all but
rs17782313, which could be genotyped in 99.9% of the partic-
ipants. Genotyping accuracy for our single nucleotide
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polymorphisms (SNPs), as determined by concordance between
duplicates, was 100%. Genotype frequencies of all SNPs were in
Hardy-Weinberg equilibrium (Table 1).
Data analysis
Weight, BMI, thicknesses, waist circumference, SBP, and
triglycerides were log transformed to obtain a better approxi-
mation of the normal distribution, before calculating age- and
sex-specific z scores with the use of means and SDs.
We performed multiple linear regression analyses for weight,
height, BMI, skinfold thicknesses, and %BF z scores and all
components of the metabolic syndrome, ie, waist circumference,
SBP, DBP, glucose, HDL cholesterol, and triglycerides z scores.
On the basis of previous reports (7, 15, 26), INSIG2 genotypes
were analyzed under a recessive model; FTO and MC4R geno-
types under an additive model. We adjusted all models for age
and pubertal stage. To evaluate the influence on overweight
(including obesity) and the metabolic syndrome, we performed
multiple logistic regression analyses. In all regression analyses,
we evaluated the interaction of genotypes with sex and physical
activity by adding a multiplicative term to the models. We also
evaluated the interaction between genotypes.
Because weight and height were also measured at age 11 y and
age 13.5 y and skinfold thicknesses at age 11 y, we additionally
performed repeated-measures analyses (ie, linear mixed-effect
models) for weight, height, BMI, and skinfold thicknesses to
assess the association between the genotypes and changes in
weight, height, and BMI (3 time points) and thicknesses (2 time
points) from age 11 y to age 16 y. Simultaneous adjustment for
age and pubertal stage in these repeated-measures analyses was
not feasible because of multicollinearity. Because pubertal stage
had the highest number of missing values, the models were
adjusted only for age. In subanalyses, we evaluated the in-
teraction between genotypes and the interaction between geno-
types and physical activity and sex by adding multiplicative
terms.
We used Quanto to calculate the power available to detect
main effects and interaction effects in our cross-sectional
analyses (see supplementary Tables 1 and 2 under “Supple-
mental data” in the online issue) (41). All other statistical
analyses were performed by using SPSS version 14.0 (SPSS,
Chicago, IL). The level of statistical significance was set at
a probability of ,0.05.
RESULTS
Our population consisted of 663 girls and 612 boys, with
a mean (6SD) age of 16.2 6 0.67 y. At this age, 12.4% were
overweight and 2.7% were obese (Table 2). Compared with
girls, boys showed less advanced pubertal stage, were more
physically active, were heavier and taller, and had a lower BMI,
sum of skinfold thicknesses, and %BF (Table 2). The prevalence
of the metabolic syndrome was 4.5%. Significant sex differences
were found for all metabolic characteristics (Table 3). To
evaluate selection bias, we compared the 1275 participants in-
cluded in this study with the original sample of 1868 children
who participated in the BMI measurements at age 11 y. Com-
pared with the 593 who were either excluded (n = 25) or lost to
TABLE 1





P value11 12 22
INSIG2 1275 7566605 0.48 0.43 0.10 0.31 0.968
FTO 1275 9939609 0.39 0.47 0.14 0.38 0.967
MC4R 1274 17782313 0.56 0.37 0.06 0.25 0.837
MC4R 1275 17700633 0.49 0.43 0.09 0.30 0.562
1 1 = major allele, 2 = minor allele. MAF, minor allele frequency;
HWE, Hardy-Weinberg equilibrium (determined by Pearson’s chi-square
test).
TABLE 2
Sociodemographic and anthropometric characteristics according to sex
All Girls Boys
P for sex effect1Value n Value n Value n
Age (y) 16.2 6 0.72 1275 16.3 6 0.7 663 16.2 6 0.6 612 0.17
Pubertal stage in 3 categories (%)3 15.9/28.7/55.4 1199 0.8/0.3/98.9 631 32.7/60.2/7.0 568 ,0.001
Physical activity (% sufficient)4 29.8 1230 26.4 644 33.6 586 0.01
Socioeconomic status in 3 categories (%)5 19.4/50.3/30.3 1263 18.5/52.4/29.0 658 20.3/47.9/31.7 605 0.28
Weight (kg) 63.1 (57.7–70.3)6 1244 60.6 (55.5–66.0) 645 66.0 (60.0–74.6) 599 ,0.001
Height (cm) 174.5 6 8.9 1248 169.2 6 6.3 649 180.3 6 7.6 599 ,0.001
BMI (kg/m2) 20.75 (19.20–22.55) 1244 21.21 (19.56–22.93) 645 20.27 (18.81–22.19) 599 ,0.001
Overweight/obese (%) 12.4/2.7 1244 14.0/2.2 645 10.7/3.2 599 0.13
Sum of skinfold thicknesses (mm) 47 (32–65) 1236 59 (47–73) 642 32 (26–47) 594 ,0.001
Body fat (%) 28.2 6 5.6 1222 31.3 6 4.3 631 25.0 6 4.8 591 ,0.001
Waist circumference (cm) 73.8 (70.0–78.9) 1243 73.8 (69.7–79.4) 647 73.8 (70.3–78.3) 596 0.51
1 P values were obtained by using a chi-square test for pubertal stage, physical activity, socioeconomic status, and overweight or obese; a t test for age,
height, and percentage body fat; and a Mann-Whitney U test for weight, BMI, sum of skinfold thicknesses, and waist circumference.
2 Mean 6 SD (all such values).
3 Measured by the Physical Development Scale questionnaire and classified as pre/early pubertal, midpubertal, and late/postpubertal.
4 Sufficient physical activity defined as 60 min of moderate or vigorous physical activity 5 d/wk, in accordance with international recommendations.
5 On the basis of questionnaires and classified as low, medium, and high.
6 Median; interquartile range in parentheses (all such values).
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follow-up (n = 568) between the first and third assessment visits,
there were no statistically significant differences in BMI z score
(P = 0.19) and sum of thicknesses z score (P = 0.07).
Because the analyses of sum of skinfold thicknesses provided
results similar to those from the analyses of all 4 thicknesses
separately, only analyses regarding the former were reported. For
none of the models, the interaction with sex was significant.
Therefore, we did not report these results.
INSIG2
We found no associations between the SNP near INSIG2 and
measures of overweight or metabolic traits, neither in the cross-
sectional analyses (Table 4) nor in the repeated-measures
analyses (Table 5).
FTO
Linear regression analyses under an additive model, adjusted
for sex and pubertal stage, showed that rs9939609 was signifi-
cantly associated with weight (B: 0.11; P = 0.01), BMI (B: 0.11;
P = 0.01), sum of skinfold thicknesses (B: 0.12; P = 0.004), %
BF (B: 0.11; P = 0.01), waist circumference (B: 0.11; P = 0.01),
and fasting glucose (B: 0.10; P = 0.04) (Table 4). FTO explained
0.5–0.7% of the variance in these outcome measures. Adjust-
ment for BMI or %BF in the model for waist circumference
resulted in nonsignificant results for FTO genotype. Adjustment
for BMI, %BF, or waist circumference in the association be-
tween FTO and glucose did not change the results (all B values =
0.10; P = 0.048, 0.044, and 0.042, respectively). No significant
modification by physical activity was found in the associations
TABLE 3
Metabolic characteristics according to sex
All Girls Boys
P for sex effect1Value n Value n Value n
Systolic blood pressure (mm Hg) 117 (109–127)2 1252 113 (107–122) 652 122 (113–132) 600 ,0.001
Diastolic blood pressure (mm Hg) 61 6 73 1252 62 6 7 652 61 6 7 600 ,0.001
Glucose (mmol/L) 4.5 6 0.4 955 4.5 6 0.4 504 4.6 6 0.4 451 ,0.001
Insulin (mU/L) 12.0 (9.1–15.3) 948 12.1 (9.5–16.0) 503 11.0 (8.5–15.0) 445 0.003
Total cholesterol (mmol/L) 3.8 6 0.7 956 4.0 6 0.7 505 3.6 6 0.7 451 ,0.001
HDL cholesterol (mmol/L) 1.5 6 0.3 956 1.5 6 0.3 505 1.4 6 0.3 451 ,0.001
LDL cholesterol (mmol/L) 2.2 6 0.6 956 2.4 6 0.6 505 2.2 6 0.6 451 ,0.001
Triglycerides (mmol/L) 0.69 (0.52–0.92) 956 0.72 (0.56–0.96) 505 0.63 (0.49–0.88) 451 ,0.001
Metabolic syndrome (%)4 4.5 — 4.5 — 4.5 — 0.96
1 P values were obtained by using a chi-square test for the metabolic syndrome; a t test for diastolic blood pressure, glucose, total cholesterol, and HDL
and LDL cholesterol; and a Mann-Whitney U test for systolic blood pressure, insulin, and triglycerides.
2 Median; interquartile range in parentheses (all such values).
3 Mean 6 SD (all such values).
4 Defined according to the International Diabetes Federation criteria on the basis of age-specific cutoffs for waist circumference, triglycerides, HDL
cholesterol, blood pressure, and glucose.
TABLE 4














Overweight1 1160 0.88 (0.50, 1.56) 1.34 (1.06, 1.69)2 1.20 (0.93, 1.54) 1.18 (0.92, 1.51)
Metabolic syndrome3 886 2.28 (0.96, 5.41) 2.05 (1.27, 3.31)2 1.43 (0.86, 2.38) 0.99 (0.58, 1.67)
Weight z score4,5 1173 20.06 (20.25, 0.12) 0.11 (0.03, 0.19)2 0.05 (20.04, 0.14) 0.07 (20.02, 0.16)
Height z score4 1176 20.13 (20.32, 0.06) 0.02 (20.06, 0.11) 20.08 (20.17, 0.01) 20.02 (20.11, 0.07)
BMI z score4,5 1173 0.01 (20.19, 0.19) 0.11 (0.03, 0.19)2 0.11 (0.02, 0.20)2 0.09 (0.00, 0.18)
Skinfold thickness z score4,5 1166 20.05 (20.24, 0.14) 0.12 (0.04, 0.20)2 0.05 (20.04, 0.14) 0.06 (20.03, 0.15)
% Body fat z score4 1154 0.04 (20.15, 0.23) 0.11 (0.03, 0.19)2 0.04 (20.05, 0.14) 0.06 (20.02, 0.15)
Waist circumference z score4,5 1172 20.05 (20.24, 0.14) 0.11 (0.03, 0.19)2 0.07 (20.02, 0.16) 0.06 (20.03, 0.15)
Systolic blood pressure z score4,5 1178 0.02 (20.17, 0.21) 0.07 (20.02, 0.15) 0.08 (20.01, 0.18) 0.03 (20.07, 0.11)
Diastolic blood pressure z score4 1178 0.09 (20.10, 0.28) 0.02 (20.07, 0.10) 0.04 (20.06, 0.13) 20.05 (20.14, 0.04)
Glucose z score4 906 0.09 (20.13, 0.31) 0.10 (0.00, 0.20)2 0.04 (20.07, 0.15) 20.04 (20.15, 0.06)
HDL-cholesterol z score4 906 20.03 (20.25, 0.19) 0.02 (20.08, 0.11) 20.04 (20.14, 0.07) 20.11 (20.21, 20.00)2
Triglycerides z score4,5 906 20.01 (20.23, 0.20) 0.01 (20.08, 0.11) 20.04 (20.14, 0.07) 0.03 (20.07, 0.13)
1 Odds ratios (95% CIs) are reported from multiple logistic regression analyses adjusted for pubertal stage.
2 P , 0.05.
3 Odds ratios (95% CIs) are reported from multiple logistic regression analyses adjusted for age, sex, and pubertal stage.
4 B values (95% CIs) are reported from multiple linear regression analyses adjusted for age and pubertal stage.
5 Log-transformed before calculation of z scores to obtain a better approximation of the normal distribution.
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between FTO genotype and overweight measures or glucose
(see supplementary Table 3, A–E, under “Supplemental data” in
the online issue).
Logistic regression analyses showed that FTO was signifi-
cantly associated with overweight and the metabolic syndrome
after adjustment for sex and pubertal stage (Table 4). Per A al-
lele, the OR of being overweight at age 16 y was 1.34 (P =
0.01), and the OR of developing the metabolic syndrome at
age 16 y was 2.05 (P = 0.003). Adjustment for BMI in the meta-
bolic syndrome model resulted in a nonsignificant OR of 1.66
(P = 0.09).
Repeated-measures analyses for BMI and sum of skinfold
thicknesses, also under an additive model, showed the same
pattern of results (Table 5). There were no significant interactions
between FTO and age, which indicated that the associations of
FTO with BMI and sum of skinfold thicknesses remained sim-
ilar from 11 to 16 y of age (Figure 1A). As is clear from the
figure, a recessive model for FTO gives the best description of
our data (B: 0.21; P = 0.01). However, in line with the original
articles and to limit the number of tests, we only presented re-
sults from the additive models. We found no significant in-
teraction effect with physical activity, neither in the model for
BMI (B = 20.06; 95% CI: 20.24, 0.11; P = 0.47) nor in the
model for sum of skinfold thicknesses (B: 0.01; 95% CI: 20.16,
0.19; P = 0.88) (see supplementary Table 4, A and B, under
“Supplemental data” in the online issue).
MC4R
Cross-sectional regression analyses adjusted for sex and pu-
bertal stage showed that under an additive model, rs17782313
was significantly associated with BMI per minor allele increase in
z score (OR: 0.11; P = 0.02), but not with overweight (OR: 1.20;
P = 0.17). The variance explained by rs17782313 was 0.5%. In
addition, rs17700633 was associated with HDL cholesterol (B:
20.11, P = 0.04), and there was a trend for BMI (B: 0.09, P =
0.05). Adjustment for BMI in the model for HDL cholesterol
resulted in nonsignificant results. No association was found
between the SNPs nearMC4R and height. We evaluated possible
modification by physical activity in the associations with BMI
and HDL cholesterol, but we found no significant interactions (P
values ranging from 0.09 to 0.55). (See supplementary Table 3,
A and F, under “Supplemental data” in the online issue.)
Repeated-measures analyses for BMI, also under an additive
model, showed similar effect sizes compared with the cross-
sectional analyses for rs17782313 (B: 0.12, P = 0.01) and
rs17700633 (B: 0.08, P = 0.047) (Table 5). In the model con-
taining both SNPs, only rs17782313 remained significantly as-
sociated with BMI z score (rs17782313, B: 0.10, P = 0.03; and
rs17700633, B: 0.04, P = 0.33). There were no interactions
between MC4R genotypes and time, which suggested a stable
association between age 11 y and age 16 y (Figure 1B). We
found no interactions with physical activity and no significant
associations between variation near MC4R and sum of skinfold
thicknesses, similar to the cross-sectional analyses.
When we included the FTO SNP (rs9939609) and rs17782313
in the same linear regression model for BMI at age 16 y, we
TABLE 5














Weight z score 1273 0.02 (20.14, 0.19) 0.06 (20.01, 0.13) 0.05 (20.03, 0.13) 0.06 (20.02, 0.13)
Height z score 1274 20.10 (20.28, 0.07) 0.01 (20.07, 0.08) 20.08 (20.16, 0.00) 20.01 (20.09, 0.07)
BMI z score2 1273 0.07 (20.11, 0.24) 0.09 (0.01, 0.16)3 0.12 (0.03, 0.20)3 0.08 (0.00, 0.16)3
Skinfold thickness z score2 1258 0.03 (20.15, 0.20) 0.10 (0.02, 0.18)3 0.06 (20.03, 0.15) 0.04 (20.04, 0.12)
1 All values are B values (95% CIs) that were reported from linear mixed models including age.
2 Outcome variables were log-transformed before calculating z scores to obtain a better approximation of the normal distribution.
3 P , 0.05.
FIGURE 1. Association between FTO single nucleotide polymorphism
rs9939609 and BMI (A) and between MC4R single nucleotide polymorphism
rs17782313 and BMI (B) from ages 11 to 16 y.
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found no evidence for interaction (P = 0.88). In the model
containing both SNPs, rs9939609 (B: 0.11; P = 0.01) and
rs17782313 (B: 0.11; P = 0.02) were independently associated
with BMI (Figure 2). Similar findings were obtained from the
repeated-measures analyses (B values of 0.08 and 0.12 and
P values of 0.03 and 0.01, respectively).
DISCUSSION
We studied the association of common variation in 3 genes
discovered through genome-wide association studies with
overweight and its associated metabolic traits in adolescence. In
line with other large studies (9–11, 13, 42), we found no asso-
ciations with the SNP near INSIG2, which supports the hy-
pothesis that an important role for INSIG2 in the etiology of
childhood overweight is unlikely. In contrast, we were able to
replicate associations for FTO and the variants near MC4R.
FTO
The A allele of SNP rs9939609 was associated with higher
BMI, sum of skinfold thicknesses, %BF,waist circumference, and
fasting glucose. ForBMI and sum of skinfold thicknesses wewere
able to establish that these associations were already present at
age 11 y and persisted throughout adolescence to age 16 y. In
addition, for each A allele in the FTO SNP, the risk of adolescent
overweight increased by 1.34, and the risk of the metabolic syn-
drome increased by 2.05. Adjustment for BMI in the metabolic
syndrome model rendered the association nonsignificant, which
suggests that the effect of FTO variation on the metabolic syn-
drome was mediated by BMI. Our findings are in line with pre-
vious research in adolescents in which each A allele was found to
be associated with an increase in BMI z score of 0.05–0.12 and
with anOR of 1.27 of being overweight (15). Furthermore, similar
variances in BMI have been reported (14, 15, 21). In addition, we
foundno associationswith lipidmeasurements, which agreedwith
the findings of a previous study in morbidly obese adults (17).
However, Freathy et al (31) found statistically significant associ-
ations of FTO with glucose, insulin, triglycerides, and HDL.
These associations were all driven by BMI. Furthermore, the
minor allele frequency (MAF) in our study (0.38) was slightly
lower than that reported inHapMap (0.45 inEuropeans), but lower
frequencies were found in other studies (19, 21). Finally, in line
with one of the original articles on FTO (15), we found no in-
teraction with sex in the association with BMI.
Our results from both the cross-sectional and repeated-
measures analyses suggest that physical activity does not modify
the association between FTO variation and overweight. This
finding is in contrast with that of other studies in a middle-aged
Danish population (n = 5554) (12), in Amish adults (43), and
more recently in a large UK population (n = 20,374) (44). This
discrepancy may partly be explained by our smaller population,
which resulted in a lower power to detect significant effects (see
supplementary Table 2 under “Supplemental data” in the online
issue). In addition, we measured physical activity differently.
Because no gold standard exists for measuring physical activity
by questionnaire, we used a measure based on international
recommendations to divide the participants into clear subgroups
of those with insufficient (70.2%) and those with sufficient
(29.8%) exercise. However, the subgroup that does not suffi-
ciently exercise is rather large, which could have influenced our
findings. Cauchi et al (45) found an interaction between FTO
and physical activity in their adolescent Finnish population (n =
4780), but not in their middle-aged French population (n =
3167). In line with our study, Jonsson et al (46) found no
interaction between rs9939609 and physical activity on BMI in
a large study among 15,925 Swedish and 2511 Finnish adults.
This is also supported by a study in twins, in which the FTO ·
environment interaction was studied in general (47).
The function of the FTO gene remains unknown. Whereas
some studies suggest that it plays a role in central regulation of
body weight (14, 48), Wa˚hle´n et al (30) studied FTO with regard
to fat cell function and adipose tissue gene expression. Their
results suggest that FTO could be involved in body weight
regulation through lipolysis. However, our results and those of
others (17), in which no association was found with triglycerides
or cholesterol, do not support this hypothesis (31).
MC4R
Variation nearMC4Rwas associated with BMI z score. The per
minor allele increase of 0.11 in BMI z score we found for
rs17782313 was similar to the value of 0.10–0.13 described by
Loos et al (26) in children aged 7–11 y. Also, similar to their
findings, the effects were stronger for rs17782313 than for
rs17700633, ie, the effect was driven by rs17782313. Addition-
ally, the associations between the SNPs nearMC4R and BMIwere
stable between ages 11 and 16 y. TheMAFswe found for the SNPs
nearMC4R were in line with the frequencies previously reported
(26). Although no direct evidence exists for a functional role of
these variants (or the variants they tag) inMC4R expression, it has
been described that the phenotypic pattern (positive association
with height, which we were not able to replicate) is similar to the
phenotype caused by rare MC4R mutations (26). In addition, the
larger effect sizes found in children than in adults (26) suggest an
association with early-onset obesity, similar to the effect of rare
MC4R mutations.
The rs17782313 in MC4R was significantly associated with
only BMI, and— although the association is in the same direction
FIGURE 2. Association between rs9939609 (FTO) and rs17782313
(MC4R) genotypes at age 16 y. Both single nucleotide polymorphisms
showed a significant additive effect: rs9939609 (P = 0.01) and rs17782313
(P = 0.02).
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— was not significantly associated with other measures of body
fat, unlike FTO. This finding was probably due to the (near-
significant) negative association between rs17782313 and height,
which is larger than its positive effect on weight. Thus, the minor
allele of rs17782313 is associated with a higher BMI through its
combined effect on lower height and higher weight, which sug-
gests thatMC4R influences BMI in a different manner than FTO.
Including the FTO SNP and rs17782313 in the same model
showed that they were independently associated with BMI,
which suggests that their effects are additive. This has also been
shown by Loos et al (26).
The main strength of our study was that we genotyped a ho-
mogeneous population of reasonable size in which multiple
phenotypic measurements of overall and abdominal adiposity as
well as associated metabolic traits were obtained. Power cal-
culations using previously reported effect sizes for BMI z scores
showed that, with an a of 0.05, our sample size (n = 1275) had
a power of 28% to detect a cross-sectional association for
rs7566605, 84% for rs9939609, 81% for rs17782313, and 15%
for rs17700633 (see supplementary Table 1 under “Supple-
mental data” in the online issue). To our knowledge, this was the
first population-based study to evaluate the influence of both
FTO and variation near MC4R, not only on overall adiposity but
also on abdominal adiposity and its related metabolic traits. In
addition, we were able to evaluate associations with BMI and
sum of skinfold thicknesses at both age 11 y and 16 y in re-
peated-measures analyses, which strengthens our findings for all
outcome measures at age 16 y.
A potential limitation of our study was the dropout rate in
TRAILS (31.7%), which was mainly due to a refusal to par-
ticipate. Evaluation of selection bias did not show statistically
significant differences between the participants and the group lost
to follow-up, but a difference in sum of skinfold thicknesses
cannot be excluded entirely. The fact that we found lower MAFs
than reported in HapMap could suggest that a leaner population
participated in the follow-up visit. Nevertheless, it seems unlikely
that this would affect the associations between genetic variants
and the outcome variables of interest. In addition, the fact that
our associations of BMI and sum of skinfold thicknesses were
consistent across assessment visits renders it unlikely that a se-
lection bias affected our findings. Another point of discussion is
the use of the IDF criteria for the metabolic syndrome. Although
dichotomizing an outcome measure does have its disadvantages,
such as loss of power (49), we used the IDF criteria to enhance the
comparability with other studies.
In conclusion, in our population of 16-y-old adolescents, we
found that variation near the MC4R gene was positively asso-
ciated with BMI. In addition, variation in the FTO gene was not
only positively associated with measures of overall fat but also
with measures of abdominal fat. The associations were stable
between ages 11 and 16 y. Our findings strengthen and extend
the results from previous genome-wide association studies.
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